Panagora Asset Management Inc Biocryst Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 676,292 shares of BCRX stock, worth $5.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

676,292

Previous 650,318 3.99%

Holding current value

$5.19 Million

Previous $4.02 Million 27.9%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $166,493 - $225,714	25,974 Added 3.99%	676,292 $5.14 Million
Q2 2024 Jul 29, 2024	BUY	$4.13 - $6.79 $73,344 - $120,583	17,759 Added 2.81%	650,318 $4.02 Million
Q1 2024 May 07, 2024	SELL	$4.89 - $7.65 $178,524 - $279,286	-36,508 Reduced 5.46%	632,559 $3.21 Million
Q4 2023 Feb 08, 2024	SELL	$4.98 - $6.77 $290,896 - $395,456	-58,413 Reduced 8.03%	669,067 $4.01 Million
Q3 2023 Oct 31, 2023	BUY	$6.71 - $7.92 $281,625 - $332,410	41,971 Added 6.12%	727,480 $5.15 Million
Q2 2023 Aug 11, 2023	SELL	$6.96 - $8.81 $44,363 - $56,154	-6,374 Reduced 0.92%	685,509 $4.83 Million
Q1 2023 May 11, 2023	SELL	$7.94 - $11.84 $29,520 - $44,021	-3,718 Reduced 0.53%	691,883 $5.77 Million
Q4 2022 Feb 13, 2023	BUY	$10.5 - $14.2 $2.03 Million - $2.74 Million	193,020 Added 38.41%	695,601 $7.99 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $1.26 Million - $1.73 Million	116,879 Added 30.3%	502,581 $6.33 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $49,754 - $112,751	-6,306 Reduced 1.61%	385,702 $4.08 Million
Q1 2022 May 12, 2022	BUY	$11.56 - $19.76 $745,342 - $1.27 Million	64,476 Added 19.69%	392,008 $6.37 Million
Q4 2021 Feb 10, 2022	BUY	$11.18 - $15.46 $1.16 Million - $1.61 Million	104,126 Added 46.61%	327,532 $4.54 Million
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $3.13 Million - $3.89 Million	220,496 Added 7577.18%	223,406 $3.21 Million
Q2 2021 Aug 11, 2021	BUY	$9.5 - $17.24 $23,037 - $41,806	2,425 Added 500.0%	2,910 $46,000
Q1 2021 May 12, 2021	BUY	$7.37 - $13.61 $1,105 - $2,041	150 Added 44.78%	485 $5,000
Q4 2020 Feb 10, 2021	BUY	$3.37 - $8.61 $1,128 - $2,884	335 New	335 $2,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Biocryst Pharmaceuticals Inc Transaction History